Loading...
Anteris Technologies Ltd
AMEUF•PNK
Healthcare
Medical - Devices
$5.70
$-3.18(-35.81%)

The company's financials show resilient growth, with revenue advancing from $2.35M in Q2 2023 to $2.13M in Q2 2024. Gross profit remained healthy with margins at 42% in Q2 2024 compared to -505% in Q2 2023. Operating income hit -$52.36M last quarter, sustaining a consistent -2462% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$51.32M. Net income dropped to -$50.83M, while earnings per share reached -$2.75. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan